Published in:
01-04-2016
A prospective study of appetite and food craving in 30 patients with Cushing’s disease
Authors:
Eliza B. Geer, Yelena Lalazar, Lizette M. Couto, Vanessa Cohen, Lianna R. Lipton, Wei Shi, Emilia Bagiella, Irene Conwell, Joshua Bederson, Jane Kostadinov, Kalmon D. Post, Pamela U. Freda
Published in:
Pituitary
|
Issue 2/2016
Login to get access
Abstract
Context
Glucocorticoid (GC) exposure increases food intake, but the mechanisms in humans are not known. Investigation of appetite and food craving has not been done in patients with chronic GC exposure due to Cushing’s disease (CD), either before or after treatment, and could provide insight into mechanisms of food intake and obesity in these patients.
Purpose
To examine whether surgical remission of CD changes appetite (prospective consumption, hunger, satisfaction, and fullness) and food cravings (sweet, salty, fatty, and savory); and to identify predictors of appetite and craving in CD remission.
Methods
30 CD patients, mean age 40.0 years (range 17–70), mean BMI 32.3 ± 6.4, were prospectively studied before and at a mean of 17.4 mo. after remission. At each visit fasting and post-test meal (50 % carbohydrate, 35 % protein, 15 % fat) appetite and craving scores were assessed.
Results
Remission decreased prospective consumption, sweet and savory craving (p < 0.05), but did not change hunger, satisfaction, fullness, or fat craving, despite decreases in BMI and fat mass. In CD remission, serum cortisol predicted lower satisfaction and fullness, and masses of abdominal fat depots predicted higher hunger and consumption (p < 0.05).
Conclusions
Chronic GC exposure in CD patients may stimulate the drive to eat by enhancing craving, rather than regulating the sensation of hunger. Continued alterations in appetite regulation due to abdominal fat mass and circulating cortisol could play a role in the cardiovascular and metabolic risk that has been reported in CD patients despite remission.